Long-Term Liabilities: The sum of all non-current liabilities.
Jazz Pharmaceuticals PLC (JAZZ) had Long-Term Liabilities of $5.10B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$4.27B |
|
$-356.15M |
|
$503.30M |
|
$3.76B |
|
$4.70B |
|
$-430.24M |
|
$-197.62M |
|
$-627.86M |
|
$-627.86M |
|
$-355.42M |
|
$-356.15M |
|
$-356.15M |
|
$-355.42M |
|
$-430.24M |
|
$266.06M |
|
60.98M |
|
60.98M |
|
$-5.84 |
|
$-5.84 |
|
| Balance Sheet Financials | |
$4.17B |
|
$199.86M |
|
$7.49B |
|
$11.66B |
|
$2.24B |
|
$4.33B |
|
|
Long-Term Liabilities |
$5.10B |
$7.34B |
|
$4.32B |
|
$-1.94B |
|
$4.32B |
|
61.44M |
|
| Cash Flow Statement Financials | |
$1.36B |
|
$-1.51B |
|
$-873.38M |
|
$2.41B |
|
$1.39B |
|
$-1.02B |
|
$291.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.86 |
|
-- |
|
-- |
|
0.50 |
|
1.24 |
|
88.21% |
|
-10.08% |
|
-10.08% |
|
6.23% |
|
-14.71% |
|
-8.35% |
|
$467.13M |
|
-- |
|
-- |
|
-- |
|
0.37 |
|
1.21 |
|
5.14 |
|
71.05 |
|
-8.25% |
|
18.36% |
|
-3.05% |
|
-4.12% |
|
$70.30 |
|
$7.66 |
|
$22.23 |
|